- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06260488
Histological Segmentation of the Superficial Femoral Artery From Microscan to CT Using Artificial Intelligence (CTPred)
Histological Segmentation of the Superficial Femoral Artery From Microscan to CT Using Artificial Intelligence: a Feasibility Study (CTPred)
The femoropopliteal artery segment (FPAS) is one of the longest arteries in the human body, undergoing torsion, compression, flexion and extension due to lower limb movements. Endovascular surgery is considered to be the treatment of choice for the peripheral arterial disease, the results of which depend on the physiological forces on the arterial wall, the anatomy of the vessels and the characteristics of the lesions being treated. The atheromatous disease includes, in a simple way, 3 categories of plaques: calcified, fibrous, and lipidic. The study of these plaques and their differentiation in imaging and histology in the FPAS has already been the subject of research. To treat them, there are angioplasty balloons and stents with different designs and components, with different mechanical properties and different impregnated molecules.
There is no non-invasive method (imaging) to accurately differentiate lesions along the FPAS. The analysis is performed from the preoperative CT scan, but there are high-resolution scanners that allow a quasi-histological analysis of the tissue.
This microscanner can be used ex vivo. In the framework of a project, the learning algorithm was be créated (Convolutional Neural Networks) to automatically segment microscanner slices: after taking FPAS from amputated limbs, we correlated ex-vivo microscanner images of the arteries with their histology. The correlation was then performed manually between the microscanner images, and the histological sections obtained. the algorithm well be trained on these slices and validated its performance. The validation of the CT and microscanner concordance was the subject of scientific publications.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Salomé KUNTZ, Doctor
- Phone Number: +31 3 69 55 01 98
- Email: salome.kuntz@chru-strasbourg.fr
Study Locations
-
-
Bas-Rhin
-
Strasbourg, Bas-Rhin, France, 67 091
- Recruiting
- Hopitaux Universitaire de Strasbourg
-
Contact:
- Salomé KUNTZ, Doctor
- Phone Number: +31 3 69 55 01 98
- Email: salome.kuntz@chru-strasbourg.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion criteria:
- Male or female of legal age
- Subject with a planned transfemoral amputation in the vascular surgery department of the Hôpitaux Universitaires de Strasbourg as standard care
- Subject with a CT as part of standard care
- Subject who has given his/her non-opposition to participate in the study
Exclusion criteria:
- Impossible to give the subject informed information (subject in emergency situation, difficulties in understanding)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: transfemoral amputation
Subject with a planned transfemoral amputation in the vascular surgery department of the Hôpitaux Universitaires de Strasbourg as standard care
|
routine endovascular surgery and FPAS harvesting from amputated limbs to evaluate the technical feasibility of histological segmentation by the FPAS algorithm from CT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessing the feasibility of histological segmentation of the superficial femoral artery on preoperative microscanner using artificial intelligence
Time Frame: 1 hour
|
Rate of slices (in %) for which segmentation is considered sufficient. The quality of segmentation will be assessed by the clinician using a Likert scale. Segmentation is considered sufficient if the scale is ≥ 3 and insufficient if it is < 3 |
1 hour
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8925
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Artery Disease
-
Janssen Scientific Affairs, LLCHCA Research Institute, LLCCompletedCoronary Artery Disease (CAD) | Peripheral Artery Disease (PAD)United States
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Peripheral Artery Occlusive DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedStructural Heart Disease | Obstructive Coronary Artery Disease | Obstructive Peripheral Artery DiseaseUnited States
-
XeltisRecruitingPeripheral Artery Occlusive DiseaseCosta Rica
-
Fangge DengRecruitingPeripheral Artery Disease (PAD)China
-
Fundacion para la Formacion e Investigacion Sanitarias...Not yet recruiting
-
Rontis Hellas SAPharmassist LtdActive, not recruitingPeripheral Artery Disease (PAD)Greece
-
Azienda Ospedaliero-Universitaria di ParmaActive, not recruiting
-
Michael Lichtenberg, MDCompletedPeripheral Artery Disease (PAD)Germany
-
Helsinki University Central HospitalCompletedPeripheral Artery Occlusive Disease | Peripheral Artery Stenosis | Peripheral Artery RestenosisFinland
Clinical Trials on Endovascular surgery
-
University of CatanzaroUnknownSurgery | Outcome, Fatal | Abdominal Aortic AneurysmItaly
-
Methodist Health SystemCompletedAbdominal Aortic AneurismUnited States
-
Helsinki University Central HospitalActive, not recruitingIntracranial AneurysmFinland
-
Karolinska InstitutetOdense University Hospital; Turku University Hospital; Oslo University Hospital; Helsinki University Central Hospital and other collaboratorsRecruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Jinan Military General HospitalRecruiting
-
Sahlgrenska University Hospital, SwedenVastra Gotaland RegionCompletedCritical Limb IschemiaSweden
-
Uppsala University HospitalCompletedAcute Ischemia of Lower Limb
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingAVM (Arteriovenous Malformation) IntracranialItaly
-
Hospital Sao JoaoCompletedAbdominal Aortic Aneurysm